Dosing & Uses
Uveitis
Pending FDA approval for noninfectious uveitis of the posterior segment (NIU-PS)
Next:
Pharmacology
Mechanism of Action
Intravitreal sirolimus inhibits the protein kinase that plays a critical role in inflammation
Immunoregulation is impacted by interrupting the inflammatory cascade by inhibiting T-cell activation, differentiation, and proliferation, and also by promoting immune tolerance, which thereby increases regulatory T lymphocytes
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
